Faheem Hasnain insider trades: Kura Oncology (KURA) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Faheem reports to the SEC
and 9 more companies
Open-market buys and sales
20 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Dec 9, 2025 | KURA | ↓ Sell | 10,000 | $10.98 | $110K | Direct | Dec 10, 2025 (1d) |
| Mar 21, 2025 | KURA | ↓ Sell | 22,682 | $8.00 | $181K | Direct | Mar 24, 2025 (3d) |
| Jun 21, 2024 | GOSS | ↑ Buy | 372,000 | $0.67 | $250K | By family trust | Jun 24, 2024 (3d) |
| Mar 27, 2024 | GOSS | ↓ Sell | 23,172 | $1.16 | $27K | Direct | Mar 28, 2024 (1d) |
| Aug 11, 2023 | MRTX | ↑ Buy | 10,791 | $27.80 | $300K | By Hasnain Revocable Trust Dated 2-19-20 | Aug 14, 2023 (3d) |
| Mar 22, 2023 | GOSS | ↑ Buy | 878,572 | $1.14 | $1.0M | By family trust | Mar 22, 2023 (0d) |
| Jul 15, 2022 | GOSS | ↑ Buy | 138,696 | $7.21 | $1000K | By family trust | Jul 15, 2022 (0d) |
| Mar 23, 2022 | GOSS | ↓ Sell | 19,035 | $8.91 | $170K | Direct | Mar 24, 2022 (1d) |
| Oct 14, 2020 | GOSS | ↑ Buy | 96,520 | $10.36 | $1000K | By family trust | Oct 14, 2020 (0d) |
| Sep 27, 2019 | GOSS | ↑ Buy | 10,000 | $16.80 | $168K | By family trust | Sep 27, 2019 (0d) |
| May 30, 2019 | TOCA | ↑ Buy | 43,000 | $4.66 | $200K | By Faheem Hasnain and Marie Hasnain Co-T | Jun 3, 2019 (4d) |
| Sep 13, 2018 | VTL | ↓ Sell | 177,443 | $0.44 | $78K | Direct | Sep 17, 2018 (4d) |
| Sep 14, 2017 | VTL | ↑ Buy | 59,200 | $4.19 | $248K | Direct | Sep 15, 2017 (1d) |
| Apr 19, 2017 | TOCA | ↑ Buy | 100,000 | $10.00 | $1.0M | By Faheem Hasnain and Marie Hasnain Co-T | Apr 21, 2017 (2d) |
| Aug 12, 2016 | VTL | ↑ Buy | 118,243 | $5.92 | $700K | Direct | Aug 15, 2016 (3d) |
| Nov 11, 2014 | RCPT | ↓ Sell | 200,000 | $109.47 | $21.9M | Direct | Nov 12, 2014 (1d) |
| Jul 9, 2008 | BIIB | ↓ Sell | 36,837 | $62.07 | $2.3M | Direct | Jul 10, 2008 (1d) |
| Apr 8, 2008 | BIIB | ↓ Sell | 6,425 | $64.47 | $414K | Direct | Apr 10, 2008 (2d) |
| May 23, 2007 | BIIB | ↓ Sell | 7,446 | $49.00 | $365K | Direct | May 24, 2007 (1d) |
| Oct 2, 2006 | BIIB | ↓ Sell | 11,244 | $44.63 | $502K | Direct | Oct 3, 2006 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other KURA insiders
Open-market trades in the last 12 months
About Faheem Hasnain's insider trades
Faheem Hasnain is an insider at Kura Oncology (KURA). Since Oct 2, 2006, Faheem has reported 10 open-market purchases worth $5.9M and 10 sales worth $26.0M on SEC Form 4. In the last 12 months: 1 sale ($110K).
Their filings also include grants and awards (65 filings), shares returned to the company (8 filings), shares withheld for taxes (8 filings), option exercises (6 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every KURA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.